On December 10, Gelonghui (600222.SH) announced that Tailong Pharmaceutical (), the controlling shareholder of the company, proposed to the board of directors that the company use its own capital to buy back some of the shares and use the repurchased shares for employee stock ownership plans or equity incentives at an appropriate time in the future. The repurchase amount is not less than RMB 30 million (inclusive) and no more than RMB 60 million (inclusive); the price of repurchase shares: no more than 150% of the average trading price of the company's stock in the first 60 trading days before the board of directors passes the repurchase decision.
太龙药业(600222.SH)：控股股东泰容产投提议3000万元-6000万元回购股份
Tailong Pharmaceutical (600222.SH): Controlling shareholder Tailong Industrial Investment proposed a share repurchase of 30 million yuan to 60 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.